# PubMed record PMID 41506099

> PeptideScanner retained PubMed bibliographic metadata for PMID 41506099 at 2026-07-30T16:14:13.082Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-01-08. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41506099-abaloparatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41506099-abaloparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41506099-abaloparatide-v1.json
- Content SHA-256: `0e2d5ba9b05b2920f9e169c5ed08c629896edd45b3ed9de9f3acb12fc8f5718e`

## Claims and source pins

### Headline

PubMed record PMID 41506099 ([`pubmed-observation-pmid-41506099-2026-06-25-bbd2f6fbe969`](#source-pubmed-observation-pmid-41506099-2026-06-25-bbd2f6fbe969))

### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41506099 at 2026-07-30T16:14:13.082Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-01-08. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41506099-2026-06-25-bbd2f6fbe969`](#source-pubmed-observation-pmid-41506099-2026-06-25-bbd2f6fbe969))

### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41506099 at 2026-07-30T16:14:13.082Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-01-08. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41506099-2026-06-25-bbd2f6fbe969`](#source-pubmed-observation-pmid-41506099-2026-06-25-bbd2f6fbe969))

### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41506099-2026-06-25-bbd2f6fbe969`](#source-pubmed-observation-pmid-41506099-2026-06-25-bbd2f6fbe969))

## Sources

<a id="source-pubmed-observation-pmid-41506099-2026-06-25-bbd2f6fbe969"></a>
- **PubMed record PMID 41506099 · retained source version 1:2026-06-25:current:bbd2f6fbe96905556c8207ca3220190b1aadd8c5e5bd9ee7fc43a69eec42f918** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41506099/) (`pubmed-observation-pmid-41506099-2026-06-25-bbd2f6fbe969`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "PubMed record PMID 41506099." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41506099-abaloparatide-v1.json SHA-256: 0e2d5ba9b05b2920f9e169c5ed08c629896edd45b3ed9de9f3acb12fc8f5718e.